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Ethnic Coefficients for Glomerular Filtration Rate Estimation by 
the Modification of Diet in Renal Disease Study Equations in the 
Korean Population
Race and ethnicity are influential in estimating glomerular filtration rate (GFR). We aimed 
to find the Korean coefficients for the Modification of Diet in Renal Disease (MDRD) study 
equations and to obtain novel proper estimation equations. Reference GFR was measured 
by systemic inulin clearance. Serum creatinine (SCr) values were measured by the alkaline 
picrate Jaffé kinetic method, then, recalibrated to CX3 analyzer and to isotope dilution 
mass spectrometry (IDMS). The Korean coefficients for the 4 and 6 variable MDRD and 
IDMS MDRD study equations based on the SCr recalibrated to CX3 and to IDMS were 
0.73989/0.74254 and 0.99096/0.9554, respectively. Coefficients for the 4 and 6 variable 
MDRD equations based on the SCr measured by Jaffé method were 1.09825 and 1.04334, 
respectively. The modified equations showed better performances than the original 
equations. The novel 4 variable equations for Korean based on the SCr measured and 
recalibrated to IDMS were 107.904×SCr
−1.009×age
−0.02 (×0.667, if woman) and 
87.832×SCr
−0.882×age
0.01 (×0.653, if woman), respectively. Modified estimations of the 
MDRD and IDMS MDRD study equations with ethnic coefficients and the novel equations 
improve the performance of GFR estimation for the overall renal function. 
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INTRODUCTION
Chronic kidney disease (CKD) is a world-wide public health 
problem with adverse outcomes. Strategies to improve out-
comes will require a global effort to detect patients with mild 
renal dysfunction (1). 
  Glomerular filtration rate (GFR) is traditionally considered 
the best overall index of renal function in health and disease (2). 
Estimation of GFR has been considered to be important with 
the increasing emphasis on the earlier detection and manage-
ment of CKD. An accurate, convenient, and reproducible GFR 
estimation will help clinicians to understand the relatively cor-
rect prevalence of CKD and follow a proper action plan for pa-
tients with CKD (3). However, routine estimated GFR (eGFR) 
reporting with serum creatinine (SCr) values is not yet univer-
sal, and underestimation of reference GFR in higher renal func-
tion is a limitation of current estimating equations, especially 
for the screening of CKD or the determination of CKD preva-
lence in the general population (4). The National Kidney Dis-
ease Education Program (NKDEP) currently recommends that 
GFR estimated above 60 mL/min/1.73 m
2 be reported simply 
as >60 mL/min/1.73 m
2 rather than as a discrete numeric value 
(5, 6). In addition, there is no significant change of SCr levels at 
near-normal GFR values (7). 
  Kidney Disease: Improving Global Outcomes (KDIGO) de-
clared that estimating equations for GFR should be developed 
in large cohort including a variety of racial and ethnic groups 
for international comparisons (1). Additionaly, the Kidney Dis-
ease Outcome Quality Initiative (K/DOQI) of the National Kid-
ney Foundation recommends that GFR should be estimated 
from SCr values and by using the abbreviated Modification of 
Diet in Renal Disease (aMDRD) study equation in order to pre-
dict kidney function and make a diagnosis of CKD (8). The MDRD 
study equation is significantly affected by race and ethnicity. A 
study of African-American has demonstrated that the ethnicity 
may influence GFR estimation by SCr based equations (2, 9). 
And Chinese and Japanese coefficients for the MDRD study 
equations were also reported (3, 8). Lee CS, et al.  •  Korean Coefficients for the MDRD Study Equations
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  Although race is a very important element for estimating GFR, 
the Asian population was not included in the MDRD study. Fur-
ther, equations from Chinese and Japanese studies are not im-
mediately applicable to the Korean population because there 
are demographic differences among ethnicities and some meth-
odological limitations in developing each coefficient. Therefore, 
we aimed to derive the ethnic coefficients of the MDRD study 
equations for Korean and to obtain novel proper estimating 
equations. 
MATERIALS AND METHODS
Subjects 
We recruited CKD patients (n=120) in outpatient department 
and healthy volunteers (n=31) from Seoul National University 
Hospital for the clinical study, ‘Measurement of glomerular fil-
tration rate and calculation of GFR estimates for Korean’ grant-
ed by the Korean Society of Nephrology from April 2008 to Feb-
ruary 2009. All of volunteers showed normal urinalysis and their 
systemic inulin clearances were greater than 60 mL/min/1.73 
m
2 (66.4-151.3 mL/min/1.73 m
2). Inclusion criteria were as fol-
lows: 1) participants who agreed with the study and voluntarily 
signed on informed consent, 2) aged 18 yr or older. Exclusion 
criteria of this study were as follows: 1) rapid decline of renal 
function within 3 months, 2) edema or ascites, 3) proteinuria 
greater than 10 g/day or serum albumin less than 2.5 g/dL, 4) 
active infection, 5) coronary artery intervention i.e., coronary 
artery bypass graft (CABG) or percutaneous coronary interven-
tion (PCI) within 1 yr (except stabilization after unstable angina 
or heart failure), 6) liver enzyme abnormality (serum AST/ALT 
greater than 2×upper normal range), 7) history of severe allergy 
like angioedema, 8) pregnant or lactating women, 9) gross hema-
turia, 10) oliguria less than 500 mL/day), 11) renal replacement 
therapy. This study was approved by the Institutional Review 
Board of Seoul National University Hospital (IRB No. 0701-006-
193).
Measurements
Inulin clearance (Inutest) (10)
Reference GFR was measured by systemic inulin clearance (Clin) 
(Inutest
® 25%, Fresenius Kabi Austria GmbH, Austria), in which 
sinistrin, an inulin analogue, is used as a substitute for inulin 
because it is more water soluble and easy to handle. The proce-
dure started after an overnight fasting except for pure water one 
hour prior to injection. Two intravenous lines, one for injection 
and the other for sampling, were established. Hydration to pro-
duce a good urine volume was achieved by oral loading with 
pure water (10 mL/kg) for 2.5 hr. Participants had abstained from 
high integrity carbohydrate such as coffee, black tea, sugar, or 
juice. A blank blood sample was drawn, and inulin was then in-
jected. We used a single shot method: A total of 20 mL of Inut-
est
® (5 g Sinistrin: equivalent to bounded fructose) was mixed 
with 30 mL of normal saline, and the mixture was injected at a 
constant rate over one minute. Participants drank 50 mL of pure 
water every 30 min. Six consecutive blood samplings (5, 10, 15, 
30, 75, and 150 min after the injection) were collected from the 
antecubital vein of opposite from inulin injection. Each blood 
sample was centrifuged at 2,500 rpm for 10 min. After serum 
extraction, it was preserved at −80°C until analysis.
  Inulin concentration (μg/mL) was determined by HPLC meth-
od (11). The HPLC system, with a delivery system, autoinjector, 
and ultraviolet detector was a Gilson Model (Gilson Inc., 305/ 
306 HPLC Pumps, 234 autoinjector, 118 UV detector, Villiers Le 
Bel, France). 
  Reference GFR was determined by the systemic Clin, which 
was calculated by dividing the infusion dose with the area un-
der the curve obtained by curve fitting. The plasma decay curves 
were fitted to a modified two-compartment pharmacokinetic 
model with zero order administration of the dose over one min-
ute. Inulin clearance was normalized to a standard body surface 
area of 1.73 m
2 BSA using the Dubois-Dubois formula (12).
Measurement of SCr concentration
SCr values were measured by the alkaline picrate Jaffé kinetic 
method using a Hitachi 7600 analyzer (Toshiba, 200FR, Japan). 
To ensure that our SCr values were calibrated equally to those 
in the MDRD study, we randomly selected 40 fresh frozen se-
rum samples from our specimens (ranging from 0.6 to 5.7 mg/
dL) and analyzed them in the Cleveland Clinic Reference Labo-
ratory. The SCr values measured by our laboratory can be cali-
brated to those obtained using a CX3 analyzer (Beckman Coul-
ter Inc., Fullerton, CA, USA), via a linear regression equation: 
CX3 SCr (mg/dL)=1.148×Hitachi SCr (mg/dL)−0.420 (r=0.9955, 
P<0.001). Then, the measured SCr level was recalibrated to the 
isotope dilution mass spectrometry (IDMS) (College of Ameri-
can Pathologists [CAP]). The equation of correction is as follows: 
recalibrated SCr=1.0734×measured SCr
−0.2418 (mg/dL) (r=0.9989, 
P<0.001). 
Measurement of estimated GFR (eGFR) (2, 7)
GFR estimation was calculated by the following four equations. 
● Abbreviated (a) MDRD equation=186×SCr
−1.154×age
−0.203 
(×0.742, if woman) (equation 1)
● Six variable MDRD equation=170×SCr
−0.999×age
−0.176×BUN
−0.170
×albumin
0.318 (×0.762, if woman) (equation 2)
● Four variable IDMS MDRD equation=175×SCr
−1.154×age
−0.203 
(×0.742, if woman) (equation 3)
● Six variable IDMS MDRD equation=161.5×SCr
−0.999×age
−0.176
×BUN
−0.170×albumin
0.318 (×0.762, if woman) (equation 4)
  In these equations, GFRs are expressed in mL/min/1.73 m
2, 
SCr and blood urea nitrogen (BUN) are expressed in mg/dL,  
albumin is expressed in g/dL, and age is expressed in years. The Lee CS, et al.  •  Korean Coefficients for the MDRD Study Equations
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BUN and albumin levels were measured by the urease/GLDH 
and bromocresol green (BCG) methods, respectively.
Korean coefficients of the MDRD and IDMS MDRD study equations 
and novel equations for estimating GFR
A total of 151 participants were included, and four participants 
whose GFRs exceeded 130 mL/min/1.73 m
2 were excluded. The 
remaining 147 patients were used for further analysis. We in-
tended to simplify the models by forcing the intercepts to be 
zero. We also reconstructed two additional regression models 
using the measured SCr levels, because recalibration of SCr val-
ues to the Cleveland Clinic Reference Laboratory values for ap-
plying MDRD study equations is cumbersome in clinical prac-
tice in Korea. Log transformation was applied before the linear 
regression, and linearity and equal variance tests were satisfac-
tory. Due to the concern that retransformation back to the usu-
al scale might induce bias, the eGFR equations were adjusted 
using the smearing method.
Statistical analysis
We used the R software (version 2.8.0; The Comprehensive R 
Archive Network: http://cran.r-roject.org) and SAS 9.1 (SAS In-
stitute Inc., Cary, NC, USA). A Student’s t-test was used for con-
tinuous variables and presented as mean±SD. The chi-square 
test was used for categorical variables. For comparison of meth-
ods used for GFR estimation, the method of Bland and Altman 
was applied (13). Precision was expressed as the width between 
the 95% limits of agreement. Accuracy was measured as the per-
centage of estimated GFR that did not deviate >15, 30, and 50% 
from the reference GFR (systemic Clin). Bias was measured as 
the sum of area between the axis X and the slopes in Bland and 
Altman figure. Values of P<0.05 were considered statistically 
significant. 
 
RESULTS
Baseline characteristics of participants
A total of 147 participants, excluding those whose systemic Clin 
exceeded 130 mL/min/1.73 m
2, were included in the analysis 
(CKD [n=118, 80.3%], healthy volunteer [n=29, 19.7%]). Mean 
age was 48.0 yr and 49% of the participants were female. Under-
lying causes of CKD were as follows: diabetes (12.9%), hyper-
tension (12.9%), glomerulonephritis (32.7%), polycystic kidney 
disease (2.7%), and other or unknown causes (19.7%). The mean 
value of measured SCr was 1.9 mg/dL. Systemic Clin was dis-
tributed from 4.5 to 121.1 mL/min/1.73 m
2 (mean: 55.6 mL/
min/1.73 m
2). Mean systolic and diastolic blood pressure were 
122.8 and 74.5 mmHg, respectively. Mean body mass index and 
body surface area were 23.85 kg/m
2 and 1.68 m
2, respectively 
(Table 1).
Modification of MDRD study equations and overall 
performance
In the first linear regression, the intercepts of the modified 
MDRD and IDMS MDRD study equations were different from 
zero (22.37 for aMDRD with SCr values recalibrated to CX3; 
17.15 for 4 variable IDMS MDRD). Although the intercepts of 
the modified equations were not assumed to be same with zero, 
we forced the intercepts to be zero to simplify application of the 
modified equations in real clinical practice. Then, the modified 
MDRD and IDMS MDRD study equations with ethnic coeffi-
cients were derived (equations 5-8) (Table 2).
  The overall diagnostic performances of the modified MDRD 
and IDMS MDRD equations with ethnic coefficients (equations 
5-8) were compared with those of the original MDRD and IDMS 
MDRD study equations (equations 1-4). Linear regressions were 
made using eGFR compared to reference GFR (systemic Clin). 
  The slopes of equations 1 and 2 using SCr values recalibrated 
to the CX3 analyzer were significantly closer to the identical line 
after modification (equations 5 and 6) (P<0.05). However, the 
changes of the slopes of equations 3 and 4 using SCr values re-
calibrated to IDMS were not statistically significant after modi-
fication (equations 7 and 8). The adjusted r
2 values (equations 
1-4) were not changed after modification. 
Table 1. Baseline characteristics of the participants (n=147; excluding participants 
whose reference GFR exceeded 130 mL/min/1.73 m
2)
Characteristic Mean±SD or No. (%) Range
Age (yr old)   48.0±14.99 19-80
Sex (Male:Female) 75 (51.0%):72 (49.0%)
BMI (kg/m
2) 23.85±3.297 14.48-33.93
BSA (m
2)   1.68±0.178 1.26-2.11
Underlying disease
   DM
   Hypertension
   GN
   PKD
   Others
   Healthy volunteer
19 (12.9%)
19 (12.9%)
48 (32.7%)
4 (2.7%)
28 (19.0%)
29 (19.7%)
Systolic BP (mm/Hg) 122.8±18.80   86-186
Diastolic BP (mm/Hg)   74.5±11.94   47-114
Measured SCr (mg/dL)   1.9±1.15 0.7-5.7
Corrected SCr to IDMS (mg/dL)   1.9±1.25 0.5-5.9
Corrected SCr to CX3 (mg/dL)   1.8±1.32 0.4-6.1
Hemoglobin (g/dL) 12.7±2.03   8.0-17.9
Blood urea nitrogen (mg/dL)   27.1±17.67   8-96
Albumin (g/dL)   4.3±0.36 2.9-5.1
Systemic inulin clearance  
   (mL/min/1.73 m
2 BSA)
   ≥90
   60-89
   30-59
   15-29
   <15
  55.60±27.793
19 (12.9%)
43 (29.3%)
53 (36.1%)
28 (19.0%)
4 (2.7%)
    4.5-121.1
BMI, Body mass index; BP, Blood pressure; BSA, Body surface area; CAP, College of 
American Pathologists; CX3, Beckman Synchron CX3 chemistry analyzer; DM, Diabetes 
mellitus; GN, Glomerulonephritis; IDMS, Isotope Dilution Mass Spectrometry; PKD, 
Polycystic kidney disease; SCr, Serum creatinine.Lee CS, et al.  •  Korean Coefficients for the MDRD Study Equations
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  The mean difference and absolute difference of equations 1 
and 2 significantly fell after modification (equations 5 and 6) 
(mean difference: from 4.4 and 5.2 to −7.9 and −7.1, P<0.05; 
mean absolute difference: from 15.0 and 14.8 to 12.0 and 12.1, 
P<0.05, respectively). The mean difference of equations 3 and  
4 also decreased after modification (equations 7 and 8) (from 
−4.4 and −2.3 to −4.6 and −4.5, P<0.05), but the mean absolute 
differences remained unchanged. 
  The biases of the modified MDRD study equations (equations 
5 and 6) were much less than those of the original MDRD study 
equations (equations 1 and 2). The biases of the IDMS MDRD 
study equations were not changed after the modification, with 
exception of the 6 variable IDMS MDRD study equation. Fifteen 
to thirty percent accuracy of most modified MDRD and IDMS 
MDRD study equations were higher than those of the original 
equations, although statistical significances were not valid (Table 
3, Fig. 1).
Novel GFR estimating equations and overall performance
Calibrat ed CX3 SCr values were needed for the simple modifi-
cation of the MDRD study equations (equations 1, 2, 5, and 6), 
but such calibration is not convenient for clinical application   
in Korea. Therefore, we tried to reconstruct another regression 
models with ethnic coefficients using the SCr values measured 
by the Jaffé kinetic method using a Hitachi 7600 analyzer (equa-
tions 9 and 10). These equations were also obtained after adjust-
ment using the smearing method (Table 4). 
  Then, we derived novel equations to permit more accurate 
estimation of GFR by using multiple linear regression models. 
  Equations with SCr values measured by a Hitachi 7600 ana-
lyzer included: 
● Four variable equation=107.904×SCr
−1.009×age
−0.02 (×0.667, if 
woman) (equation 11)
● Six variable equation=56.694×SCr
−0.899×age
0.01×BUN
−0.081×alb
umin
0.5 (×0.674, if woman) (equation 12)
  Equations with SCr values recalibrated to IDMS included: 
● Four variable IDMS equation=87.832×SCr
−0.882×age
0.01 (×0.653, 
Table 2. Ethnic coefficients of the MDRD study equations for Korean population (n=147; excluding participants whose reference GFR exceeded 130 mL/min/1.73 m
2)
Equation
Exponent- 
transformed intercept
Coefficient of continuous parameters Exponent-transformed coefficient  
of dichotomous variables SCr Age BUN Alb
SCr recalibrated to CX3 analyzer, Beckman (Cleveland Clinic Reference Laboratory)
   5
   6
186
170
-1.154
-0.999
-0.203
-0.176
-
-0.170
-
0.318
0.742, if woman 0.73989, if Korean
0.762, if woman 0.74254, if Korean
SCr recalibrated to IDMS (College of American Pathologists)
   7
   8
175
    161.5
-1.154
-0.999
-0.203
-0.176
-
-0.170
-
0.318
0.742, if woman 0.99096, if Korean
0.762, if woman 0.9554, if Korean
Alb, Albumin; BUN, Blood urea nitrogen; IDMS, Isotope Dilution Mass Spectrometry; MDRD, Modification of Diet in Renal Disease; SCr, Serum creatinine.
Table 3. Overall performance of the original and modified MDRD study equations (equations 1-8) compared to systemic inulin clearance (reference GFR) (n=147; excluding 
participants whose reference GFR exceeded 130 mL/min/1.73 m
2)
Intercept  
95% C.I.
Slope  
95% C.I.
Adjusted  
R
2
Median  
difference  
25%, 75% 
Median abs. 
difference  
25%, 75%
Bias Precision
Accuracy
15% 30% 50%
MDRD and IDMS MDRD study equations
aMDRD
(1)
6v MDRD
(2)
4v IDMS MDRD
(3)
6v IDMS MDRD
(4)
-7.86 
(-17.24,1.53)
-6.97 
(-16.18,2.24)
2.58  
(-3.879.04)
2.07  
(-3.84,8.95)
1.32  
(1.17,1.47)
1.31  
(1.16,1.46)
0.88  
(0.78,0.99)
0.93  
(0.828,1.03)
0.67
0.67
0.65
0.66
4.4  
(-8,21.8)
5.2  
(-7.6,24.9)
-4.4  
(-15.4,5.3)
-2.3  
(-14.7,7.4)
15.0  
(6.4,29.4)
14.8  
(6,32.1)
10.2  
(4.8,20.5)
9.9  
(5.2,19.8)
3,476.7
3,417.7
517.7
795.0
   20.7
   20.5
   17.9
18
21.1
20.4
32.7
34
50.3
51.0
61.9
64.6
74.8
74.1
82.3
82.3
MDRD and IDMS MDRD study equations multiplied by the Korean ethnic coefficients 
aMDRD
(5)
6v MDRD
(6)
4v IDMS MDRD
(7)
6v IDMS MDRD
(8)
-5.81 
(-12.75,1.13)
-5.18 
(-12.02,1.67)
2.56  
(-3.84,8.95)
1.97  
(-4.37,8.32)
 0.98*  
(0.87,1.09)
 0.97* 
(0.867,1.08)
0.88  
(0.77,0.98)
0.89  
(0.78,0.99)
0.67
0.67
0.65
0.66
-7.9*  
(-19.5,2.2)
-7.1*  
(-18.1,2)
-4.6
† 
(-15.7,4.8)
-4.5
† 
(-16,4.8)
 12.0*  
(5.8,22.7)
 12.1*  
(6.0,22.1)
10.4  
(4.6,20.5)
9.8  
(4.6,20.7)
1,129.2
1,075.1
   553.8
   573.6
   18.3
   18.1
   17.8
   17.6
29.9
   32.7*
33.3
33.3
52.4
51.7
60.5
61.2
82.3
82.3
82.3
84.4
Difference, absolute difference and precision: mL/min/1.73 m
2, Bias: arbitrary unit.
*P<0.05, compared with equation 1 and 2; 
†P<0.05, compared with equation 3 and 4.
(1-8)numbers in parenthesis mean the number of equation.
IDMS, Isotope Dilution Mass Spectrometry; MDRD, Modification of Diet in Renal Disease; SCr,Serum creatinine.Lee CS, et al.  •  Korean Coefficients for the MDRD Study Equations
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if woman) (equation 13)
● Six variable IDMS equation=71.381×SCr
−0.65×age
0.07×BUN
−0.249
×albumin
0.445 (×0.762, if woman) (equation 14)
  The slopes of equations 9 and 10 were significantly closer than 
the slopes of equations 1 and 2 to the identical line (P<0.05). The 
slopes of equations 11 and 12 were also closer than those of equa-
tions 1 and 2, although statistical significance was not valid. The 
slopes of equations 13 and 14 were more distant from the iden-
tical line than those of equations 3 and 4 (P<0.05). The values of 
the adjusted r
2 for equations 9-14 were much better than those 
for equations 1-4.
  The mean difference and absolute difference of equations 9 
and 10 decreased in comparison to equations 1 and 2 (mean 
difference: from 4.4 and 5.2 to −2.1 and −3.0, P<0.05; mean ab-
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Fig. 1. Correlation of estimated glomerular filatration rate (eGFR) (equations 1-8) with systemic inulin clearance (reference GFR) (A) and Bland and Altman plots between eGFR 
(equations 1-8) and systemic inulin clearance (B) (n=147; excluding participants whose reference GFR exceeded 130 mL/min/1.73 m
2). (A) Black line: Identical line, gray line: 
Fit line between systemic inulin clearance and eGFR. Modification of the Modification of Diet in Renal Disease (MDRD) study equations using serum creatinine (SCr) values recalibrated 
to CX3 analyzer (Cleveland Clinic Reference Laboratory) underestimated GFR for all stages of renal function. (B) Solid red line represents the regression line of difference between 
methods against average of methods. The mean difference is indicated by center line, limits of agreement are indicated by the upper (mean+2SD) and lower (mean−2SD) lines.
Eq1-Eq4: Equations 1-4: The MDRD and Isotope Dilution Mass Spectrometry (IDMS) MDRD study equations using SCr values recalibrated to CX3 analyzer and to IDMS. Eq5-
Eq8: Equations 1-4 multiplied by the Korean ethnic coefficients. Lee CS, et al.  •  Korean Coefficients for the MDRD Study Equations
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solute difference: from 15.0 and 14.8 to 9.0 and 8.2, P<0.05, re-
spectively). The mean difference and absolute difference of 
equations 11-14 decreased compared to equations 1-4. 
  The biases of equations 9-12 were much less than those of 
the original MDRD study equations (equations 1 and 2). The 
biases of the equations using SCr values recalibrated to IDMS 
increased after modification with ethnic coefficients. Fifteen to 
thirty percent accuracy of equations 9-12 were higher than those 
of the original MDRD study equations (equations 1 and 2) (P< 
0.05). Fifteen to thirty percent accuracy of equations 13 and 14 
were improved against equations 3 and 4, although statistical 
significance was not valid (Table 5, Fig. 2).
  The performance of the equations was analyzed after divid-
ing participants based on systemic Clin less than or greater than 
60 mL/min/1.73 m
2. In the group of participants with systemic 
Clin less than 60 mL/min/1.73 m
2 (n=85), the bias, precision, and 
accuracy of the original MDRD equations were not changed af-
ter the modification. In the group of participants with systemic 
Clin of 60 mL/min/1.73 m
2 or more (n=62), the bias was signifi-
cantly decreased after the modification, even though precision 
and accuracy were not significantly improved (data not shown).
DISCUSSION
About fifty thousand patients were receiving renal replacement 
therapy by the end of 2008 in Korea (hemodialysis, 33,427; peri-
toneal dialysis, 7,840; kidney transplantation, 10,722) (14). The 
number of patients and the budget to support those patients is 
increasing by a geometric progression. However, the increased 
prevalence of end stage renal disease patients accounts for just 
small portion of the huge number of CKD patients. To allow cli-
nicians to recognize early CKD patients and figure out the prev-
alence of CKD in Korean population, we derived ethnic coeffi-
cients modifying the original MDRD and IDMS MDRD study 
equations from participants with all stages of renal function. 
Ethnic coefficients for the 4 and 6 variable MDRD/IDMS MDRD 
study equations based on SCr values recalibrated to CX3 ana-
lyzer and to IDMS were 0.73989/0.74254 and 0.99096/0.9554, 
respectively, and SCr measured by the Jaffé method using a Hi-
tachi 7600 were 1.09825/1.04334 (Tables 2, 4).
  In the present study, the modified MDRD study equations 
with ethnic coefficients based on SCr values recalibrated to CX3 
analyzer (equations 5 and 6) and SCr measured by the Jaffé 
Table 4. Ethnic coefficients of the MDRD study equations for Korean population using measured serum creatinine values by a Hitachi 7600 (n=147; excluding participants 
whose reference GFR exceeded 130 mL/min/1.73 m
2)
Equation
Exponent-transformed 
intercept
Coefficient of continuous parameters Exponent-transformed 
coefficient of dichotomous 
variables SCr Age BUN Alb
Measured SCr (Hitachi 7600, Toshiba-200FR autoanalyzer)
  9 186 -1.154 -0.203 - - 0.742, if woman
1.09825, if Korean
10 170 -0.999 -0.176 -0.170 0.318 0.762, if woman
1.04334, if Korean
Alb, Albumin; BUN, Blood urea nitrogen; IDMS, Isotope Dilution Mass Spectrometry; MDRD, Modification of Diet in Renal Disease; SCr, Serum creatinine.
Table 5. Overall performance of the novel equations (equations 9-14) compared to systemic inulin clearance (reference GFR): (n=147; excluding participants whose reference 
GFR exceeded 130 mL/min/1.73 m
2)
Intercept  
95% C.I.
Slope  
95% C.I.
Adjusted  
R
2
Median    
difference   
25%, 75%
Median abs.   
difference  
25%, 75%
Bias Precision
Accuracy
15% 30% 50%
Modified MDRD study equations using measured SCr values by a Hitachi 7600 and multiplied by the Korean ethnic coefficients (9, 10)
aMDRD
(9)
6v MDRD
(10)
5.84  
(0.57,11.11)
4.77  
(-0.68,10.23)
0.86*  
(0.77,0.94)
0.87*  
(0.78,0.96)
0.73
0.72
-2.1*
(-10,7.4)
-3.0*
(-10.7,6.9)
9.0* 
(4.5,15.1)
8.2* 
(4.3,16.6)
311.4
309.7
15.1
15.5
  42.2*
  39.5*
  67.3*
  69.4*
87.8
86.4
Novel equations for Korean population using SCr values measured by a Hitachi 7600 (11, 12) and recalibrated to IDMS (13, 14)
aMDRD
(11)
6v MDRD
(12)
4v IDMS MDRD
(13)
6v IDMS MDRD
(14)
12.48  
(7.93,17.03)
11.99 
(7.41,16.56)
14.54  
(9.78,19.29)
13.86 
(9.03,18.69)
0.79*  
(0.71,0.86)
0.80*  
(0.72,0.87)
0.75
† 
(0.67,0.83)
0.76
†
(0.69,0.84)
0.75
0.76
0.72
0.72
0.4* 
(-8.2,10.4)
1.2* 
(-8.7,9.8)
0.6
†
(-11.2,10.2)
1.6
†
(-8.9,10.1)
9.1* 
(3.7,15.15)
9.2* 
(3.8,15.3)
10.7
†
(4.1,15.8)
9.6
†
(4,16.2)
604.0
534.9
769.4
656.3
13.6
13.6
14.5
14.6
  45.6*
  48.3*
43.5
45.6
  68.7*
  67.3*
70.1
66.7
86.4
87.8
86.4
87.8
Difference, absolute difference and precision: mL/min/1.73 m
2, Bias: arbitrary unit.
*P<0.05, compared with equations 1 and 2; 
†P<0.05, compared with equations 3 and 4.
(9-14)numbers in parenthesis mean the number of equation.
IDMS, Isotope Dilution Mass Spectrometry; MDRD, Modification of Diet in Renal Disease; SCr,Serum creatinine.Lee CS, et al.  •  Korean Coefficients for the MDRD Study Equations
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method using a Hitachi 7600 (equations 9 and 10) showed bet-
ter performance than did the original MDRD study equations 
(equations 1 and 2), although these improvements were not al-
ways statistically significant. These results guarantee that we 
could easily apply these ethnic coefficients and equations for 
usual clinical practice in Korea. The modified MDRD study equa-
tions with ethnic coefficients based on SCr recalibrated to CX3 
analyzer showed more underestimation. This finding may orig-
inate from our statistical intention to force the intercept to be 
zero to permit simple practical application. In fact, the intercepts 
of the modified MDRD equation were different from zero (22.37 
for the aMDRD and 21.74 for the 6 variable MDRD). Statistical 
design forcing the intercept to be zero also explains the discrep-
ancies between the Korean coefficient of 0.74 and the Japanese 
coefficient of 0.881 (8). Because the procedure of recalibration 
to the CX3 analyzer is cumbersome and impractical as well, we 
suggest that modification of the original abbreviated and 6 vari-
able MDRD equations with 1.09825 and 1.04334 (based on the 
locally measured SCr values by the Jaffé method) would be more 
clinically useful. 
  Although modification of the MDRD study equations with the 
measured SCr values (equations 9 and 10) showed sufficiently 
good slopes, biases, and accuracies, the ethnic coefficients of 
the IDMS MDRD study equations were close to ‘1’ and the mod-
ified IDMS MDRD study equations showed comparable per-
formance to equations 9 and 10. IDMS, high order reference 
method, have been developed for the assignment of reference 
materials and proficiency testing using a commutable specimen 
made each institution derives the correlation coefficient for in-
dividual measurement methods versus reference measurement 
Fig. 2. Correlation of estimated glomerular filatration rate (eGFR) (equations 9-14) with systemic inulin clearance (reference GFR) (A) and Bland and Altman plots between eGFR 
(equations 9-14) and systemic inulin clearance (B) (n=147; excluding participants whose reference GFR exceeded 130 mL/min/1.73 m
2). (A) Black line: Identical line, gray line: 
Fit line between systemic inulin clearance and eGFR. Overestimation in advanced renal dysfunction or underestimation in near normal renal function was still observed. (B) Solid 
red line represents the regression line of difference between methods against average of methods. The mean difference is indicated by center line, limits of agreement are 
indicated by the upper (mean+2SD) and lower (mean−2SD) lines. Eq9-Eq10: The Modification of Diet in Renal Disease (MDRD) study equations using locally measured serum 
creatinine (SCr) values by a Hitachi 7600 and multiplied by the Korean ethnic coefficients. Eq11-Eq14: Novel 4 and 6 variable equations using SCr values recalibrated to CX3 
analyzer (equations 11 and 12) and to Isotope Dilution Mass Spectrometry (IDMS) (equations 13 and 14).
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procedures (6, 15). Additionally, calibration improved the per-
formance of the MDRD study equation, although larger errors 
still remained for GFR estimates greater than 60 mL/min/1.73 
m
2 after calibration (16). Based on our results and those of oth-
ers, we suggest that the IDMS MDRD equation will also offer a 
plausible option hereafter.
  In contrast to the meaningful change in the GFR, there is no 
significant change in SCr levels for near normal GFR levels. The 
NKDEP currently recommends that a GFR estimated above 60 
mL/min/1.73 m
2 be reported simply as >60 mL/min/1.73 m
2 
rather than as a discrete numeric value (5, 6). Variation in the 
calibration of the SCr values, biologic and measurement vari-
ability of GFR at higher levels, and the use of an equations de-
veloped in a population with CKD provide possible explana-
tions for the variable results of estimation in a population with-
out the disease (5). In this study, percentages of estimated GFR 
above 60 mL/min/1.73 m
2 increased after the modification of 
equations 1 and 2 in CKD stage 2. Further, equations modified 
with ethnic coefficients generally showed better discrimination 
of estimated GFR less than 60 mL/min/1.73 m
2 in CKD stage 3 
(data not shown). This means that clinicians could identify pa-
tients who should be managed more carefully and prevent the 
useless consumption of medical resources. Of course, modifi-
cation of the MDRD study equations based on SCr values recal-
ibrated to CX3 analyzer (Cleveland Clinic Reference Laborato-
ry) (equations 5 and 6) may result in over-treatment of patients 
due to GFR estimation. Because the original MDRD study equa-
tions overestimated the real GFR for participants with normal 
to moderate renal dysfunction (slopes for 4 and 6 variable MDRD 
equations: 1.32 and 1.31, respectively), however, underestima-
tion with the modified MDRD study equations might help cli-
nicians to screen CKD patients more easily. In summary, we 
suggest that modification of the MDRD study equations with 
ethnic coefficients (equations 5-10) is very useful and should 
be adopted into routine clinical practice. 
  Ma et al. (3) reported that using a Chinese coefficient of 1.233 
for the original abbreviated MDRD equation improved the GFR 
estimation for the Chinese population. However, the coefficient 
of 1.233 is much higher than the Korean coefficient of 0.74 and 
the Japanese coefficient of 0.881 (based on the SCr values reca-
librated to CX3 analyzer) (8). Several criticisms to the result of 
the Chinese population study exist, including false measure-
ment unit for creatinine, use of 
99mTc-DTPA (which differs sub-
stantially from renal clearance), and GFR measurement after 
breakfast. 
125I-iothalamate and radio-labeled DTPA renal clear-
ance seem to overestimate the GFR by about 5 mL/min/1.73 m
2 
compared to inulin clearance, and Agarwal et al. reported that 
plasma clearance over 4 hr overestimated the GFR by 22% to 
50% (17, 18). All of these matters may explain the discrepancies 
among the coefficients for East Asians. 
  GFR is measured using a variety of methods and filtration 
markers. Urinary Clin, using a constant infusion, has long been 
recognized as the gold standard method (19). However, multi-
ple complications (e.g., glucose interference and the difficulty 
in adequate collection of urine) have led to the development of 
alternative methods (19). Total systemic Clin overestimated uri-
nary Clin, however, it had a much better reproducibility than did 
the urinary Clin. And the difference in results generated by the 
single injection method and continuous infusion method in 
children was small and was considered acceptable in clinical 
practice (20, 21). Determination of systemic Clin with a single 
injection method is therefore a method of general validity for 
measuring the GFR without urine collection (21, 22). Theoreti-
cally, it is even possible that the single injection method may 
provide a more accurate representation of urinary Clin than the 
continuous infusion method (23). 
  In this study, urinary Clin was greater than systemic Clin (Y= 
1.199×X+1.087, r=0.797). Multiple stepwise errors during timed 
urine collection and sample dilution occurring due to excessive 
inulin concentrations in the urine might explain this finding. 
We suggest that the acquisition of systemic Clin would offer a 
better approach to measure the GFR, and previous several evi-
dences lead us to believe that the Korean ethnic coefficients are 
more plausible than Japanese coefficients.
  When the calibration of SCr methods is traceable to the SCr 
reference system, GFR should be estimated using the MDRD 
study equation that has been re-expressed for standardized SCr 
values (23). Imai et al. reported that the Japanese coefficients 
for the 4 variable IDMS MDRD study equation was 0.763/0.808 
(24, 25). These values are markedly different from the Korean 
coefficient of 0.99. Imai et al. used continuous renal Clin to mea-
sure GFR, whereas we used total systemic Clin after single shot 
injection of inulin. Differences in the reference GFR, creatinine 
calibration, inclusion and exclusion criteria, and statistical meth-
od used may explain the differences in the coefficients for the 
two ethnicities. More studies to identify and verify the IDMS 
MDRD study equation coefficients for Korean and other popu-
lations in Asia are required. Other variables with the potential 
to predict GFR (e.g., serum cystatin C) may be included to im-
prove the performance of the GFR estimating equations, espe-
cially in the early stages of CKD (26). Recent investigations sug-
gest that cystatin C may be a better filtration marker than SCr, 
especially at higher levels of GFR. Novel estimations of GFR us-
ing cystatin C for Korean, based on the participants of this study, 
will be reported soon. 
  This study is superior to previous studies because both CKD 
patients and healthy volunteers were recruited for this study. 
Thus, ethnic coefficients and novel equations reported here are 
easily applicable for screening and monitoring CKD (27). How-
ever, it is the limitation of this study that the study population 
was restricted to patients with native kidney disease and with-
out serious comorbid conditions that would exclude them from Lee CS, et al.  •  Korean Coefficients for the MDRD Study Equations
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participating in clinical trials. And the fact that we did not vali-
date estimation equations described above is the limitation of 
this study. 
  In conclusion, Modified estimations of the MDRD and IDMS 
MDRD study equations with ethnic coefficients and the novel 
equations improve the performance of GFR estimation for the 
overall renal function. Another study to validate these estima-
tion equations and to compare systemic Clin (using sinistrin) 
with urinary inulin clearance will be needed. Furthermore, we 
assert that future studies (based on SCr values recalibrated to 
IDMS) to identify and verify the novel equations for East Asian 
population using the same GFR measurement protocol and eli-
gible criteria should be performed. 
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